![Lynette Herscha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lynette Herscha
Geschäftsführer bei
Immunitas Therapeutics, Inc.
Profil
Lynette Herscha is currently the Chief Operating Officer at Immunitas Therapeutics, Inc. She previously worked as the Secretary & General Counsel at Concert Pharmaceuticals, Inc. from 2017 to 2019.
She also held the position of Secretary & Chief Legal Officer at Solid Biosciences, Inc. Ms. Herscha received her undergraduate degree from Boston University and her graduate degree from Boston University School of Law.
Aktive Positionen von Lynette Herscha
| Unternehmen | Position | Beginn |
|---|---|---|
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Geschäftsführer | 13.07.2022 |
Ehemalige bekannte Positionen von Lynette Herscha
| Unternehmen | Position | Ende |
|---|---|---|
| CONCERT PHARMACEUTICALS, INC. | General Counsel | 01.01.2019 |
| SOLID BIOSCIENCES INC. | General Counsel | - |
Ausbildung von Lynette Herscha
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
15
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Law
 Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
